HC
PACB icon

Henshaw Capital’s Pacific Biosciences PACB Stock Holding History

Henshaw Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-48,109
Closed -$180K – 292
2024
Q1 		$180K Buy
48,109
+11,718
+32% +$68.6K 0.01% 282
2023
Q4 		$357K Buy
36,391
+4,958
+16% +$40.5K 0.02% 215
2023
Q3 		$262K Buy
31,433
+12,624
+67% +$144K 0.02% 242
2023
Q2 		$250K Hold
18,809
– – 0.01% 210
2023
Q1 		$218K Hold
18,809
– – 0.01% 229
2022
Q4 		$154K Hold
18,809
– – 0.01% 246
2022
Q3 		$109K Hold
18,809
– – 0.01% 292
2022
Q2 		$83.1K Hold
18,809
– – 0.01% 301
2022
Q1 		$171K Buy
+18,809
New +$217K 0.01% 311

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return